United States

ProPhase Labs Inc (PRPH.OQ)

PRPH.OQ on NASDAQ Stock Exchange Capital Market

24 Feb 2017
Change (% chg)

$0.06 (+2.91%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for PRPH.OQ


ProPhase Labs, Inc. is a manufacturer, marketer and distributor of a range of homeopathic and health products. The Company is also engaged in the research and development of over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. It is engaged in manufacturing,... (more)
No analyst recommendations are available for PRPH.OQ.


Beta: 0.09
Market Cap(Mil.): $35.19
Shares Outstanding(Mil.): 17.08
Dividend: --
Yield (%): --


  PRPH.OQ Industry Sector
P/E (TTM): -- 26.22 40.57
EPS (TTM): -0.21 -- --
ROI: -42.61 12.44 59.76
ROE: -42.87 16.33 67.48

BRIEF-Prophase labs announces agreement to sell cold-eeze(r) brand

* Prophase labs announces agreement to sell cold-eeze(r) brand

Jan 09 2017

BRIEF-Prophase Labs files for non-timely 10-Q

* Prophase labs-was unable to file form 10-q for september quarter because of technical connectivity difficulties between filing server and edgar server

Nov 15 2016

BRIEF-ProPhase Labs quarterly earnings per share $0.01

* Prophase labs reports financial results for the three months and nine months ended september 30, 2016

Nov 14 2016

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.